The effect and optimal dose of sufentanil in reducing injection pain of microemulsion propofol

Dong Hun Chung, Nan Sook Kim, Mi Kyoung Lee, Hee Kyung Jo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Propofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol was developed to avoid these side effects but incidence and severity of pain on injection is higher than with lipid emulsion propofol. We aimed to compare the effects of sufentanil in analgesic doses for reducing the injection pain of microemulsion propofol. Methods: The candidates included eighty patients, 19-60 years old and ASA I-II. They were randomly classified into four groups and pretreated with normal saline, sufentanil 0.1 μg/kg, 0.2 μg/kg or 0.3 μg/kg before injection of microemulsion propofol. Five minutes after receiving pretreatment drug, 2 mg/kg of microemulsion propofol was injected and VAS was recorded. Results: There were no significant differences in the incidence of injection pain among the groups. Severity of injection pain was significantly lower in the sufentanil 0.3 μg/kg group than normal saline and sufentanil 0.1 μg/kg group. Significant differences in blood pressure and heart rate were observed in sufentanil groups only after endotracheal intubation. One patient each in sufentanil 0.1 μg/kg and 0.3 μg/kg group experienced mild cough, one from sufentanil 0.3 μg/kg group experienced dizziness and another showed signs of hypoxia. One patient each in normal saline and sufentanil 0.1 μg/kg group showed clinical symptoms of phlebitis in the injection area. Conclusions: Pretreatment with sufentanil 0.3 μg/kg reduced the severity of microemulsion propofol injection pain without increasing arterial blood pressure and heart rate after endotracheal intubation.

Original languageEnglish
Pages (from-to)83-89
Number of pages7
JournalKorean Journal of Anesthesiology
Volume60
Issue number2
DOIs
Publication statusPublished - 2011 Feb 1

Fingerprint

Sufentanil
Propofol
Pain
Injections
Intratracheal Intubation
Heart Rate
Phlebitis
Incidence
Dizziness
Hyperlipidemias
Emulsions
Pulmonary Embolism
Cough
General Anesthesia
Analgesics
Arterial Pressure
Maintenance
Blood Pressure
Lipids

Keywords

  • Injection pain
  • Microemulsion propofol
  • Sufentanil

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The effect and optimal dose of sufentanil in reducing injection pain of microemulsion propofol. / Chung, Dong Hun; Kim, Nan Sook; Lee, Mi Kyoung; Jo, Hee Kyung.

In: Korean Journal of Anesthesiology, Vol. 60, No. 2, 01.02.2011, p. 83-89.

Research output: Contribution to journalArticle

@article{b6c73b3c57524c2e873b389af4959a91,
title = "The effect and optimal dose of sufentanil in reducing injection pain of microemulsion propofol",
abstract = "Background: Propofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol was developed to avoid these side effects but incidence and severity of pain on injection is higher than with lipid emulsion propofol. We aimed to compare the effects of sufentanil in analgesic doses for reducing the injection pain of microemulsion propofol. Methods: The candidates included eighty patients, 19-60 years old and ASA I-II. They were randomly classified into four groups and pretreated with normal saline, sufentanil 0.1 μg/kg, 0.2 μg/kg or 0.3 μg/kg before injection of microemulsion propofol. Five minutes after receiving pretreatment drug, 2 mg/kg of microemulsion propofol was injected and VAS was recorded. Results: There were no significant differences in the incidence of injection pain among the groups. Severity of injection pain was significantly lower in the sufentanil 0.3 μg/kg group than normal saline and sufentanil 0.1 μg/kg group. Significant differences in blood pressure and heart rate were observed in sufentanil groups only after endotracheal intubation. One patient each in sufentanil 0.1 μg/kg and 0.3 μg/kg group experienced mild cough, one from sufentanil 0.3 μg/kg group experienced dizziness and another showed signs of hypoxia. One patient each in normal saline and sufentanil 0.1 μg/kg group showed clinical symptoms of phlebitis in the injection area. Conclusions: Pretreatment with sufentanil 0.3 μg/kg reduced the severity of microemulsion propofol injection pain without increasing arterial blood pressure and heart rate after endotracheal intubation.",
keywords = "Injection pain, Microemulsion propofol, Sufentanil",
author = "Chung, {Dong Hun} and Kim, {Nan Sook} and Lee, {Mi Kyoung} and Jo, {Hee Kyung}",
year = "2011",
month = "2",
day = "1",
doi = "10.4097/kjae.2011.60.2.83",
language = "English",
volume = "60",
pages = "83--89",
journal = "Korean Journal of Anesthesiology",
issn = "2005-6419",
publisher = "Korean Society of Anesthesiologists",
number = "2",

}

TY - JOUR

T1 - The effect and optimal dose of sufentanil in reducing injection pain of microemulsion propofol

AU - Chung, Dong Hun

AU - Kim, Nan Sook

AU - Lee, Mi Kyoung

AU - Jo, Hee Kyung

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Background: Propofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol was developed to avoid these side effects but incidence and severity of pain on injection is higher than with lipid emulsion propofol. We aimed to compare the effects of sufentanil in analgesic doses for reducing the injection pain of microemulsion propofol. Methods: The candidates included eighty patients, 19-60 years old and ASA I-II. They were randomly classified into four groups and pretreated with normal saline, sufentanil 0.1 μg/kg, 0.2 μg/kg or 0.3 μg/kg before injection of microemulsion propofol. Five minutes after receiving pretreatment drug, 2 mg/kg of microemulsion propofol was injected and VAS was recorded. Results: There were no significant differences in the incidence of injection pain among the groups. Severity of injection pain was significantly lower in the sufentanil 0.3 μg/kg group than normal saline and sufentanil 0.1 μg/kg group. Significant differences in blood pressure and heart rate were observed in sufentanil groups only after endotracheal intubation. One patient each in sufentanil 0.1 μg/kg and 0.3 μg/kg group experienced mild cough, one from sufentanil 0.3 μg/kg group experienced dizziness and another showed signs of hypoxia. One patient each in normal saline and sufentanil 0.1 μg/kg group showed clinical symptoms of phlebitis in the injection area. Conclusions: Pretreatment with sufentanil 0.3 μg/kg reduced the severity of microemulsion propofol injection pain without increasing arterial blood pressure and heart rate after endotracheal intubation.

AB - Background: Propofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol was developed to avoid these side effects but incidence and severity of pain on injection is higher than with lipid emulsion propofol. We aimed to compare the effects of sufentanil in analgesic doses for reducing the injection pain of microemulsion propofol. Methods: The candidates included eighty patients, 19-60 years old and ASA I-II. They were randomly classified into four groups and pretreated with normal saline, sufentanil 0.1 μg/kg, 0.2 μg/kg or 0.3 μg/kg before injection of microemulsion propofol. Five minutes after receiving pretreatment drug, 2 mg/kg of microemulsion propofol was injected and VAS was recorded. Results: There were no significant differences in the incidence of injection pain among the groups. Severity of injection pain was significantly lower in the sufentanil 0.3 μg/kg group than normal saline and sufentanil 0.1 μg/kg group. Significant differences in blood pressure and heart rate were observed in sufentanil groups only after endotracheal intubation. One patient each in sufentanil 0.1 μg/kg and 0.3 μg/kg group experienced mild cough, one from sufentanil 0.3 μg/kg group experienced dizziness and another showed signs of hypoxia. One patient each in normal saline and sufentanil 0.1 μg/kg group showed clinical symptoms of phlebitis in the injection area. Conclusions: Pretreatment with sufentanil 0.3 μg/kg reduced the severity of microemulsion propofol injection pain without increasing arterial blood pressure and heart rate after endotracheal intubation.

KW - Injection pain

KW - Microemulsion propofol

KW - Sufentanil

UR - http://www.scopus.com/inward/record.url?scp=79952550646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952550646&partnerID=8YFLogxK

U2 - 10.4097/kjae.2011.60.2.83

DO - 10.4097/kjae.2011.60.2.83

M3 - Article

VL - 60

SP - 83

EP - 89

JO - Korean Journal of Anesthesiology

JF - Korean Journal of Anesthesiology

SN - 2005-6419

IS - 2

ER -